Cancer research
A little-known antibiotic, siomycin A, has shown early promise as a potential anti-cancer agent, targeting the FoxM1 gene that is over-expressed in most human tumors. Researchers at the University of Illinois at Chicago College of Medicine have identified siomycin A as a promising candidate using a novel screening system based
Cancer research
Researchers from the M.D. Anderson Cancer Center in the United States have made significant breakthroughs in understanding the mechanisms behind cancer development and potential treatment options. Their studies have shed light on the role of Myc overexpression and ATM kinase inactivation in tumorigenesis, as well as the importance of
Cancer research
Recent studies have reported significant advances in cancer gene therapy, with novel promoters and targeted therapies emerging as promising approaches for treating small-cell lung cancer and breast cancer. Researchers in Denmark and the United States have made groundbreaking discoveries in the field, shedding light on the potential of targeted cancer
Cancer research
Recent studies from Germany and South Korea have made significant strides in gene therapy for cancer treatment, employing novel approaches to improve efficacy and safety. In Germany, researchers have developed an improved Tet-On regulatable FasL-adenovirus vector system, demonstrating enhanced lung cancer therapy. In South Korea, scientists have explored the combination
Cancer research
Researchers at the British Columbia Cancer Research Center in Vancouver, Canada, have made significant contributions to cancer research in recent years. Their findings, published in various academic journals, have shed light on the genetic alterations and tumor microvasculature in different types of cancers. Key Takeaways: * Whole-genome tiling-path array comparative genomic
Cancer research
Researchers from the People's Republic of China, South Korea, and the United States have made significant advancements in cancer research, exploring the potential of gene therapy in treating this devastating disease. In recent studies, scientists have demonstrated the efficacy of gene transfer in preventing ovarian cancer metastasis, inhibiting
Cancer research
Recent research from Japan, Finland, and the United States has made significant strides in the field of cancer gene therapy, particularly in the treatment of malignant gliomas. A study from Kyushu University Hospital found that gene therapy using brain-specific angiogenesis inhibitor 1 (BAI1) showed promising results in inhibiting angiogenesis and
Cancer treatment
Researchers in the United States, Japan, and Australia have made significant strides in the treatment of cervical cancer through the use of RNA interference. This innovative approach involves silencing the human papillomavirus (HPV) oncogenes, which are responsible for causing the disease. Studies have shown that targeting these oncogenes can lead
Cancer treatment
Researchers from Canada, China, and the United States have made significant breakthroughs in cancer gene therapy, offering new hope for cancer patients worldwide. These studies demonstrate the potential of gene therapy in treating various types of cancers, including osteosarcoma, ovarian cancer, and pancreatic adenocarcinoma. Key Takeaways: * A Canadian study found
Cancer research
Researchers in Germany, Japan, and Finland have made significant progress in cancer treatment, developing new gene therapies that show promise in fighting various types of cancers. In Germany, scientists have created an improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy, which exhibits improved safety and efficacy. In Japan,
Cancer research
The Genome-Wide RNAi Global Initiative, an alliance of Dharmacon, Inc. and leading international research centers, has announced that Fox Chase Cancer Center of Philadelphia has joined the initiative. The collaboration aims to advance the productivity of genome-wide RNAi screening, a breakthrough in discovery biology. The addition of Fox Chase Cancer
Cancer treatment
As doctors excitement grows about the potential of Avastin, a drug already widely used for colon cancer, as a treatment for breast and lung cancer, many are cringing at the price Genentech plans to charge: about $100,000 a year. This price, more than double the current level for colon
